| Description |
aggrecan |
matrix metallopeptidase 20 |
| Image |
|
|
| Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
|
| Diseases |
|
|
| GWAS |
|
- Adverse response to antithyroid drugs in Graves disease ( 30067105)
- Neuroblastoma (11q deletion) ( 28924153)
- Night sleep phenotypes ( 27126917)
- Prostate cancer ( 23535732)
- Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score) ( 30166627)
- Urinary metabolite levels in chronic kidney disease ( 29545352)
|
| Interacting Genes |
18 interacting genes:
ADAMTS1
ADAMTS4
ADAMTS5
CTSB
FBLN1
FBLN2
HAPLN1
LUM
MMP1
MMP14
MMP19
MMP2
MMP20
MMP3
MMP8
PTPRF
TNFAIP6
TNR
|
1 interacting genes:
ACAN
|
| Entrez ID |
176 |
9313 |
| HPRD ID |
01123 |
05218 |
| Ensembl ID |
ENSG00000157766
|
ENSG00000137674
|
| Uniprot IDs |
A0A5K1VW97
P16112
|
O60882
|
| PDB IDs |
4MD4
7RDV
|
2JSD
|
| Enriched GO Terms of Interacting Partners? |
|
|
| Tagcloud ? |
|
|
| Tagcloud (Difference) ? |
|
|
| Tagcloud (Intersection) ? |
|